UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 18, 2010
Ardea Biosciences, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
|
| Delaware
|
|
1-33734
|
|
94-3200380 |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
|
| 4939 Directors Place
|
|
92121 |
| San Diego, California
|
|
(Zip Code) |
| (Address of principal executive offices) |
|
|
Registrant’s telephone number, including area code: (858) 652-6500
Not applicable.
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 7.01. Regulation FD Disclosure
The Company recently presented a poster of certain clinical data related to BAY 86-9766 (formerly
known as RDEA119) at the 22nd EORTC-NCI-AACR Symposium on “Molecular Targets and Cancer
Therapeutics” in Berlin, Germany. A copy of the poster is filed as Exhibit 99.1 to this Form 8-K
and is incorporated herein by reference in its entirety. The fact that this material is being
furnished should not be deemed an admission as to the materiality of any information contained in
the material.
The information in this Item 7.01 and Exhibits 99.1 attached hereto shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth
by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
|
|
|
| (d) |
|
Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K: |
| |
|
|
| Exhibit |
|
|
| Number |
|
Document Description |
99.1
|
|
Poster on BAY 86-9766 (formerly known as RDEA119)
presented at the 22nd EORTC-NCI-AACR
Symposium on “Molecular Targets and Cancer
Therapeutics” in Berlin, Germany. |